---
schema_version: "secwatch.filing_event.v1"
accession: "0000096943-26-000091"
form_type: "8-K"
ticker: "TFX"
cik: "0000096943"
company_name: "TELEFLEX INC"
filed_at: "2026-08-06T11:08:03+00:00"
generated_at: "2026-08-06T11:10:51.301769+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Teleflex Q2 revenue up 4.7% pro forma; cuts revenue guidance, raises adjusted EPS outlook

## Summary
- Q2 revenue $570.3M (+28.9% reported, +4.7% pro forma adj. constant currency); GAAP EPS $0.96, adj. EPS $1.76.
- Full-year 2026 pro forma adj. constant currency revenue growth guidance reduced to 3.5%-4.5%; GAAP EPS cut to $2.54-$2.84.
- Adjusted EPS guidance raised to $6.90-$7.20; includes ~19% adj. operating margin and $250M share repurchase in Q2.
- Completed OEM divestiture for $1.5B cash; paid off $700M Term Loan A-2; new $500M 5.875% senior notes due 2032.
- FDA approved EZPLAZ freeze-dried plasma; Freesolve BIOMAG-II enrollment completed ahead of schedule.

## SEC filing metadata
- accession: 0000096943-26-000091
- form_type: 8-K
- ticker: TFX
- cik: 0000096943
- company_name: TELEFLEX INC
- filed_at: 2026-08-06T11:08:03+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/96943/000009694326000091/0000096943-26-000091-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/96943/000009694326000091/tfx-20260806.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000096943-26-000091
- JSON: https://secwatch.observer/filing/0000096943-26-000091.json
- Plain text: https://secwatch.observer/filing/0000096943-26-000091.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.